Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04814914 · ClinicalTrials.gov registry record
An Observational Clinical Study to Evaluate COVID-19 Symptoms in "Long Hauler" Patients Who Participated in K031-120 or K032-120
A clinical trial, sponsored by Kaleido Biosciences.
- Completed
- Registry status
- 333
- Enrollment target
NCT04814914 is a clinical trial that has completed, run by Kaleido Biosciences. The registered enrollment target is 333 participants.
The verdict
NCT04814914 has completed, sponsored by Kaleido Biosciences.
- COMPLETED
- Registry status
- 333 participants
- Enrollment target
Study Summary
This observational clinical study aims to evaluate the presence of symptoms of COVID-19 infection in patients who participated in K031-120 or K032-120 ("long hauler").
Interventions
- OTHER Self Supportive Care (SSC) Alone
- OTHER KB109 + Self Supportive Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 333 participants |
| Start Date | 2021-03-25 |
| Est. Completion | 2021-05-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04814914
The ClinicalTrials.gov registry entry for NCT04814914 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 333 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaleido Biosciences, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Self Supportive Care (SSC) Alone is the first listed.
NCT04814914 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04814914 about?
NCT04814914 is a clinical study titled "An Observational Clinical Study to Evaluate COVID-19 Symptoms in "Long Hauler" Patients Who Participated in K031-120 or K032-120". This observational clinical study aims to evaluate the presence of symptoms of COVID-19 infection in patients who participated in K031-120 or K032-120 ("long hauler").
What is the current status of trial NCT04814914?
This trial is currently completed. The enrollment target is 333 participants. The study started on 2021-03-25. Estimated completion is 2021-05-28.
What interventions are being tested in trial NCT04814914?
The interventions under investigation include: Self Supportive Care (SSC) Alone (OTHER), KB109 + Self Supportive Care (OTHER).
Who is sponsoring clinical trial NCT04814914?
This trial is sponsored by Kaleido Biosciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.